A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration

NCT00032396 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Macular Degeneration

Interventions

DRUG: Retisert Implant

Sponsor

Control Delivery Systems

Collaborators

[object Object]